《股市简讯》中国远大医药涨4.4%,放射性药物肝癌临床试验达到临床终点

路透中文
Apr 14
《股市简讯》中国<a href="https://laohu8.com/S/00512">远大医药</a>涨4.4%,放射性药物肝癌临床试验达到临床终点

* 中国远大医药0512.HK周二早盘涨4.4%。

* 该公司此前公告称,联营公司Sirtex Medical Pty Ltd的放射性药物--易甘泰在美国开展的用于治疗不可切除肝细胞癌临床研究达到临床终点。

* 远大医药今年迄今大跌13.9%,同期恒生指数.HSI上扬0.6%。

* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度升1.4%。(完)

更多股市简讯请点选CN-CMN-HOT

(发稿 徐凯文;审校 吴云凌)

((kaiwen.xu@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10